Update on ovarian cancer screening. Munkarah A,
Department of Obstetrics and Gynecology, Division of Gynecologic
Oncology, Wayne State University School of Medicine, USA bProgram in Molecular
Biology and Human Genetics, Karmanos Cancer Institute/Wayne State University,
USA cDepartment of Pathology, and Center for Molecular Medicine and Genetics,
Wayne State University School of Medicine, Detroit, Michigan, USA. Epithelial ovarian cancer is usually diagnosed in the advanced stage and
carries a poor prognosis. When detected at an early stage, the 5-year survival
rate is 90%. Despite the availability of various diagnostic tools for ovarian
cancer screening, high levels of sensitivity and specificity are not achievable.
There is therefore an ongoing need to identify new screening tests and
strategies that should be readily available, relatively noninvasive, and achieve
high sensitivity, specificity, and positive and negative predictive values.
RECENT Our review focuses on various screening technologies including serum
biomarkers, transvaginal ultrasonography as well as multimodality screening that
can be used for early detection of ovarian cancer. The efficacy of different
screening tools is discussed along with the efforts made to improve sensitivity,
specificity and positive predictive value. The initial results of two large
population-based screening studies are presented. An optimal screening test with high levels of sensitivity and specificity is
indispensable for early detection of ovarian cancer. Serological screening with
serum biomarkers (serum proteins and autoantibodies) can be used as a first-line
screening test. In combination with TVS or color-flow Doppler imaging, this may
prove very effective in early detection of ovarian cancer.
Please click on the required question. Thank
you for choosing to visit us. This is the personal website of
David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at
Whipps Cross University Hospital, London - Specialist Interests - Reproductive Medicine including Infertility, PCOS, PMS, Menopause and HRT. I do hope that you find the answers to your women's health questions in the
patient information and medical advice provided. If you still have
unanswered questions, please consider entering them into one of our
forums and I will try to assist you.Purpose of Review
Findings:
Summary
Reducing the Risks of Womens' Cancers.
Cancer of the Cervix.
Endometrial Cancer (Uterus)
Cancer of the Ovary.
The Treatment Of Womens' Cancers
Cancer of the Vulva, Vagina and Fallopian Tube
Breast Cancer
Web sites and Support Groups
- Introduction
- Abortion
- Amenorrhoea
- Birth Control
- Bladder Symptoms
- Cancer in Women
- Childbirth
- Children and Teenagers
- Diet / Weight Loss
- Dysmenorrhoea
- Endometriosis
- Female Sexual Problems
- Fibroids
- HRT Risks v Benefits
- Hirsutism
- Hysterectomy
- Infections
- Infertility
- Medication Drugs
- Menopause
- Menorrhagia
- Miscarriage
- Painful Sex
- Pap Smear Test
- PCOS
- Pelvic Pain
- PMS
- Postpartum
- Pregnancy & Childbirth
- Vaginal Discharge
- Vaginal Prolapse
- Vulval Symptoms
Underperforming Family Website?
This website
2womenshealth.com
is the
most popular personal website
in its category
1.5 million visitors annually.
The author has applied
his clinical and
scientific research experience
to
the application of techniques to
promote your web pages.
Visit
Now
Promote Your
Family Website
Improve Your Business Income



